Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 40: 18-23, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwertner, H. A.
Right arrow Articles by Tolan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwertner, H. A.
Right arrow Articles by Tolan, G.

Clinical Chemistry, Vol 40, 18-23, Copyright © 1994 by American Association for Clinical Chemistry

Association of low serum concentration of bilirubin with increased risk of coronary artery disease

HA Schwertner, WG Jackson and G Tolan
USAF Medical Center/RDL, Lackland AFB, TX 78236-5319.

We examined serum bilirubin and various liver-function enzymes as possible risk factors for angiographically documented coronary artery disease (CAD). The studies involved a "training" set of 619 men for whom complete data on all risk factors considered were available, and a "test" set of 258 men for whom some risk factor data were not available. In both study groups, the liver enzymes were not related to CAD; however, In[total bilirubin] was inversely and statistically significantly related to the presence of CAD, both univariately and multivariately after adjustment for the established risk factors of age, total cholesterol, high-density lipoprotein cholesterol, smoking history, and systolic blood pressure. A 50% decrease in total bilirubin was associated with a 47% increase in the odds of being in a more severe CAD category. Our data suggest that serum bilirubin is an inverse and independent risk factor for CAD, with an association equivalent in degree to that of systolic blood pressure.


The following articles in journals at HighWire Press have cited this article:


Home page
StrokeHome page
H. Kimm, J. E. Yun, J. Jo, and S. H. Jee
Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence: A Prospective Study in Korean Men and Women
Stroke, November 1, 2009; 40(11): 3422 - 3427.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. D. Johnson, M. Kavousi, A. V. Smith, M.-H. Chen, A. Dehghan, T. Aspelund, J.-P. Lin, C. M. van Duijn, T. B. Harris, L. A. Cupples, et al.
Genome-wide association meta-analysis for total serum bilirubin levels
Hum. Mol. Genet., July 15, 2009; 18(14): 2700 - 2710.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. K. Idriss, A. D. Blann, and G. Y.H. Lip
Hemoxygenase-1 in Cardiovascular Disease
J. Am. Coll. Cardiol., September 16, 2008; 52(12): 971 - 978.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Y.-H. Chen, L.-Y. Chau, J.-W. Chen, and S.-J. Lin
Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients
Diabetes Care, August 1, 2008; 31(8): 1615 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Rantner, B. Kollerits, M. Anderwald-Stadler, P. Klein-Weigel, I. Gruber, A. Gehringer, M. Haak, M. Schnapka-Kopf, G. Fraedrich, and F. Kronenberg
Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study
Clin. Chem., May 1, 2008; 54(5): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. S. Perlstein, R. L. Pande, J. A. Beckman, and M. A. Creager
Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. W. Ryter, D. Morse, and A. M. K. Choi
Carbon Monoxide and Bilirubin: Potential Therapies for Pulmonary/Vascular Injury and Disease
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Stocker and M. A. Perrella
Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?
Circulation, November 14, 2006; 114(20): 2178 - 2189.
[Full Text] [PDF]


Home page
CirculationHome page
J.-P. Lin, C. J. O'Donnell, J. P. Schwaiger, L. A. Cupples, A. Lingenhel, S. C. Hunt, S. Yang, and F. Kronenberg
Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study
Circulation, October 3, 2006; 114(14): 1476 - 1481.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. W. Ryter, J. Alam, and A. M. K. Choi
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Physiol Rev, April 1, 2006; 86(2): 583 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. I. Goodman, P. N. Chander, R. Rezzani, M. L. Schwartzman, R. F. Regan, L. Rodella, S. Turkseven, E. A. Lianos, P. A. Dennery, and N. G. Abraham
Heme Oxygenase-2 Deficiency Contributes to Diabetes-Mediated Increase in Superoxide Anion and Renal Dysfunction
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1073 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. A. Kirkby and C. A. Adin
Products of heme oxygenase and their potential therapeutic applications
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Gullu, D. Erdogan, D. Tok, S. Topcu, M. Caliskan, T. Ulus, and H. Muderrisoglu
High Serum Bilirubin Concentrations Preserve Coronary Flow Reserve and Coronary Microvascular Functions
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2289 - 2294.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Morita
Heme Oxygenase and Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. N. Hopkins, L. L. Wu, S. C. Hunt, and E. A. Brinton
Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1003 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Keshavan, T. L. Deem, S. J. Schwemberger, G. F. Babcock, J. M. Cook-Mills, and S. D. Zucker
Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration
J. Immunol., March 15, 2005; 174(6): 3709 - 3718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, G. Li Volti, A. I. Goodman, and A. Kappas
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2468 - H2477.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. W. Sedlak and S. H. Snyder
Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle
Pediatrics, June 1, 2004; 113(6): 1776 - 1782.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. A. Schwertner
Bilirubin Concentration, UGT1A1*28 Polymorphism, and Coronary Artery Disease
Clin. Chem., July 1, 2003; 49(7): 1039 - 1040.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Endler, A. Hamwi, R. Sunder-Plassmann, M. Exner, T. Vukovich, C. Mannhalter, J. Wojta, K. Huber, and O. Wagner
Is Low Serum Bilirubin an Independent Risk Factor for Coronary Artery Disease in Men but Not in Women?
Clin. Chem., July 1, 2003; 49(7): 1201 - 1204.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. Novotny and L. Vitek
Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies
Experimental Biology and Medicine, May 1, 2003; 228(5): 568 - 571.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. E. Baranano, M. Rao, C. D. Ferris, and S. H. Snyder
From the Cover: Biliverdin reductase: A major physiologic cytoprotectant
PNAS, December 10, 2002; 99(25): 16093 - 16098.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Kaneda, M. Ohno, J. Taguchi, M. Togo, H. Hashimoto, K. Ogasawara, T. Aizawa, N. Ishizaka, and R. Nagai
Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1680 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
W. Durante
Carbon monoxide and bile pigments: surprising mediators of vascular function
Vascular Medicine, August 1, 2002; 7(3): 195 - 202.
[Abstract] [PDF]


Home page
Int J EpidemiolHome page
P. G. V. Hoydonck, E. H. Temme, and E. G Schouten
Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes
Int. J. Epidemiol., December 1, 2001; 30(6): 1465 - 1472.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Ishizaka, Y. Ishizaka, E. Takahashi, M. Yamakado, and H. Hashimoto
High Serum Bilirubin Level Is Inversely Associated With the Presence of Carotid Plaque
Stroke, February 1, 2001; 32 (2): 580 - 583.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Mayer
Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease
Clin. Chem., November 1, 2000; 46(11): 1723 - 1727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Cunningham, A. Dunne, P. Sabido, D. Lightner, and T. J. Mantle
Studies on the Specificity of the Tetrapyrrole Substrate for Human Biliverdin-IXalpha Reductase and Biliverdin-IXbeta Reductase. STRUCTURE-ACTIVITY RELATIONSHIPS DEFINE MODELS FOR BOTH ACTIVE SITES
J. Biol. Chem., June 16, 2000; 275(25): 19009 - 19017.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Durante, K. J. Peyton, and A. I. Schafer
Platelet-Derived Growth Factor Stimulates Heme Oxygenase-1 Gene Expression and Carbon Monoxide Production in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2666 - 2672.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury
PNAS, March 2, 1999; 96(5): 2445 - 2450.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. C.M. Siow, H. Sato, and G. E. Mann
Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
Cardiovasc Res, February 1, 1999; 41(2): 385 - 394.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Beutler, T. Gelbart, and A. Demina
Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?
PNAS, July 7, 1998; 95(14): 8170 - 8174.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. P. Tracy
Inflammation in Cardiovascular Disease : Cart, Horse, or Both?
Circulation, May 26, 1998; 97(20): 2000 - 2002.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Hunt, L. L. Wu, P. N. Hopkins, and R. R. Williams
Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 912 - 917.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 250 - 255.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. W. Bowry, D. Mohr, J. Cleary, and R. Stocker
Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density Lipoprotein
J. Biol. Chem., March 17, 1995; 270(11): 5756 - 5763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.